ScreenerHero

CDT CDT Equity Inc.

NAS · US · Healthcare · Biotechnology · cdtequity.com
0.8360USD-10.12%Mkt Cap: 33892 $P/E: 0.00

CDT Equity Inc., a data-driven biopharmaceutical company, focuses on identifying, enhancing, and monetising therapeutic assets. The company's pipeline includes AZD1656, a glucokinase activator that is in Phase II trials …

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap33.89K USD
Enterprise Value464.27K USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-39.22M USD
Revenue/Share—
Last Price0.8360 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees4
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)0.00
P/E (Forward)—
PEG—
EV/EBITDA-0.02
EV/Revenue—
P/S—
P/B0.00
EPS (TTM)90812.50
EPS (Forward)—
52W Range
0.80410% of range44450.00
52W High44450.00 USD
52W Low0.8041 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE547.06%
ROA-694.23%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-15.55M USD
CapEx (TTM)2.40M USD
FCF Margin—
FCF Yield57880.55%
Net Debt435.00K USD
Net Debt/EBITDA-0.02
Balance Sheet
Debt/Equity-0.11
Current Ratio0.13
Quick Ratio0.04
Book Value/Sh4084.02 USD
Cash/Share23.74 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:25
Split DateSep 29, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.40.54K
Float22.43K
Insiders29.61%
Institutions0.06%
Short Interest
Short Ratio0.1d
Short % Float1.26%
Short % Out.1.25%
Shares Short9.60K
Short (prev mo.)398
Technical
SMA 5039.46 (-97.9%)
SMA 2002431.39 (-100.0%)
Beta1.56
S&P 52W Chg16.45%
Avg Vol (30d)337.70K
Avg Vol (10d)611.27K
Technical Indicators
RSI (14)18.4
MACD-13.2408
MACD Signal-16.3227
MACD Hist.+3.0819
BB Upper12.85 USD
BB Middle4.282 USD
BB Lower-4.2870 USD
BB Width400.26%
ATR (14)3.381 USD
Vol Ratio (20d)0.99x